Login
$EBS Congressional Trades
$7.09 +$0.42 (6.3%) Close

Congressional Trades in Emergent BioSolutions Inc.

What members of the House and Senate report owning and trading in EBS, as filed with the House Clerk and the Senate. Every row links to the filing it came from.

Trades, last 12 months
0
by 0 members
Buys / sells
0 / 0
0 bought, 0 sold
Members reporting EBS
0
in their latest annual report
Reported after the trade
–
median, last 12 months

Members who report holding EBS

As filed in each member's latest annual report, in the ranges the form uses.

No sitting member's latest annual report lists EBS.

Traded Member Trade Amount Investor Reported Source
Oct 18, 2021 Josh Gottheimer House · D · NJ-5 Buy · Stock $1K – $15K Joint Nov 15, 2021 28 days later Filing
Nov 24, 2020 Gilbert Ray Cisneros, Jr. House · D · CA-31 Buy · Stock $1K – $15K Self Dec 15, 2020 21 days later Filing
Jul 30, 2020 Gilbert Ray Cisneros, Jr. House · D · CA-31 Buy · Stock $1K – $15K Self Aug 19, 2020 20 days later Filing
Jun 30, 2020 Gilbert Ray Cisneros, Jr. House · D · CA-31 Buy · Stock $1K – $15K Self Jul 17, 2020 17 days later Filing
Jun 26, 2020 Josh Gottheimer House · D · NJ-5 Buy · Stock $1K – $15K Joint Jul 9, 2020 13 days later Filing

Listed in annual reports

Transactions an annual report lists for the year it covers, apart from trade reports. Not counted in the trades above.

Traded Member Trade Amount Investor Report
Mar 26, 2020 Steve Cohen Partial sale · Stock $1K – $15K Self 2020 Annual Report filed Aug 13, 2021

Members report each trade in a range, not an exact amount, and have up to 45 days to report it. Some filings are scans; where we could not read a scanned field with confidence it is left blank rather than guessed, and the filing link shows the original.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support